Levophencynonate

DB16011InvestigationalSmall molecule

Levophencynonate is under investigation in clinical trial NCT02299804 (A Clinical Trial to Evaluate Efficacy and Safety of Levophencynonate Hydrochloride in Patient With Vertigo).

Mechanism: Pharmacologically active on Muscarinic acetylcholine receptor
Curator reviewed
Formula / weight: C₂₂H₃₁NO₃ · 357.494 g/mol (avg)
Also known as: Levo-phencynonate

Resolves to

Compound

UNII4TNV157KEQCAS230313-75-4

Structure

InChIKeyROZOEEGFKDFEFP-JLPZCGHASA-NSMILES[H][C@]12CCC[C@]([H])(CN(C)C1)C2OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1

What you can answer from here — as of August 29, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of Levophencynonate, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account